L vs SNOA · P/E 14, rev $18.45B vs rev $19.5M
Loews Corp (L) versus Sonoma Pharmaceuticals Inc (SNOA) — a side-by-side from cached financials, not a winner call.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Sonoma Pharmaceuticals Inc (SNOA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
Latest reported SNOA revenue for 2026-03-31 was $19.5M. Net income was -$3.2M. Revenue was up 36.7% from 2025-03-31 to 2026-03-31. SNOA currently screens at market cap $4.9M.
L currently screens at market cap $22.36B and trailing P/E 13.8. SNOA currently screens at market cap $4.9M.
Not investment advice. Open the L and SNOA stock pages for the full models.
Not investment advice.